The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
HMGB1: Endogenous Danger Signaling
Open accessAbstract
While foreign pathogens and their products have long been known to activate the innate immune system, the recent recognition of a group of endogenous molecules that serve a similar function has provided a framework for understanding the overlap between the inflammatory responses activated by pathogens and injury. These endogenous molecules, termed alarmins, are normal cell constituents that can be released into the extracellular milieu during states of cellular stress or damage and subsequently activate the immune system. One nuclear protein, High mobility group box-1 (HMGB1), has received particular attention as fulfilling the functions of an alarmin by being involved in both infectious and non-infectious inflammatory conditions. Once released, HMGB1 signals through various receptors to activate immune cells involved in the immune process. Although initial studies demonstrated HMGB1 as a late mediator of sepsis, recent findings indicate HMGB1 to have an important role in models of non-infectious inflammation, such as autoimmunity, cancer, trauma, and ischemia reperfusion injury. Furthermore, in contrast to its pro-inflammatory functions, there is evidence that HMGB1 also has restorative effects leading to tissue repair and regeneration. The complex functions of HMGB1 as an archetypical alarmin are outlined here to review our current understanding of a molecule that holds the potential for treatment in many important human conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“High mobility group box protein 1 (HMGB1) [198–200] and M-CSF [201] have also been suggested to be produced by osteocytes that stimulate osteoclast recruitment during bone remodeling [72, 73].”
From Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells (2015) · cites this paper as [199]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Tolerance, Danger and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 5,107
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 1×
“These findings are validated further by the observation that node positive breast cancer patients carrying a loss of function TLR4 allele tend to relapse more quickly after treatment with chemo-radiation as compared to patients with wild-type TLR4 alleles (107,108).”
ResultDAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1594 · Cited by 2,490
Innate Immunity: The Virtues of a Nonclonal System of Recognition
Medzhitov, R., & Janeway, C. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80412-2 · Cited by 2,434
Decoding the Patterns of Self and Nonself by the Innate Immune System
Medzhitov, R., & Janeway, C. A. (2002) · Science · doi:10.1126/science.1068883 · Cited by 2,154
Research works printed but not linked: 1
- Medawar PB, Woodruff MF. (1958) The induction of tolerance by skin homografts on newborn rats. Immunology. 1:27–35.
Cited by
Sorted by citations
Items 101–200 of 760
New drugs for exacerbations of chronic obstructive pulmonary disease
Hansel, T. T., & Barnes, P. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61342-8 · Cited by 112
Immune responses in cardiac repair and regeneration: a comparative point of view
Lai, S.-L., Marín‐Juez, R., & Stainier, D. Y. R. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2995-5 · Cited by 112
Ogiku, M., Kono, H., Hara, M., Tsuchiya, M., & Fujii, H. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.182592 · Cited by 107
Au, A. K., Aneja, R. K., Bell, M. J., Bayır, H., Feldman, K., Adelson, P. D., Fink, E. L., Kochanek, P. M., & Clark, R. S. B. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2011.2171 · Cited by 105
Reeves, R. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.09.015 · Cited by 110
Thermal ablation and immunomodulation: From preclinical experiments to clinical trials
Takaki, H., Cornélis, F., Kako, Y., Kobayashi, K., Kamikonya, N., & Yamakado, K. (2017) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2017.04.008 · Cited by 104
Bauer, E. M., Shapiro, R. A., Zheng, H., Ahmad, F., Ishizawar, D. C., COMHAIR, S. A. A., ERZURUM, S. C., Billiar, T. R., & Bauer, P. M. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00283 · Cited by 104
Self-citationInflammatory Response After Laparoscopic Versus Open Resection of Colorectal Liver Metastases
Fretland, Å. A., Sokolov, A., Postriganova, N., Kazaryan, A. М., Pischke, S. E., Nilsson, P. H., Rognes, I. N., Bjørnbeth, B. A., Fagerland, M. W., Mollnes, T. E., et al. (2015) · Medicine · doi:10.1097/md.0000000000001786 · Cited by 102
High-mobility group box 1 (HMGB1) as a master regulator of innate immunity
Castiglioni, A., Canti, V., Rovere, P. Q., & Manfredi, A. A. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1033-1 · Cited by 104
Haj-Mirzaian, A., Amiri, S., Amini-Khoei, H., Hosseini, M.-J., Haj-Mirzaian, A., Momeny, M., Rahimi-Balaei, M., & Dehpour, A. R. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.10.023 · Cited by 100
Schade, G. R., Wang, Y.-N., DʼAndrea, S., Hwang, J. H., Liles, W. C., & Khokhlova, T. D. (2018) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2018.09.006 · Cited by 100
Giordano, C., Mojumdar, K., Liang, F., Lemaire, C. F., Li, T., Richardson, J., Divangahi, M., Qureshi, S. T., & Petrof, B. J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu735 · Cited by 102
Zheng, X., Zhao, Y., Jia, Y., Shao, D., Zhang, F., Sun, M., Dawulieti, J., Hu, H., Cui, L., Pan, Y., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120716 · Cited by 98
Wang, K., Yu, G., Zhang, Z.-Y., Huang, Q., & Dong, X. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.07.002 · Cited by 99
Morrell, E. D., Kellum, J. A., Pastor‐Soler, N. M., & Hallows, K. R. (2014) · Critical Care · doi:10.1186/s13054-014-0501-5 · Cited by 97
Converging Actions of Alcohol on Liver and Brain Immune Signaling
Szabó, G., & Lippai, D. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00011-7 · Cited by 96
Rashidah, N. H., Lim, S. M., Neoh, C. F., Majeed, A. B. A., Tan, M. P., Khor, H. M., Tan, A. H., Rehiman, S. H., & Ramasamy, K. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101744 · Cited by 100
Wang, J., Li, R., Peng, Z., Hu, B., Rao, X., & Li, J. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4530 · Cited by 98
Durán-Flores, D., & Heil, M. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.10.010 · Cited by 94
Apoptotic Osteocytes and the Control of Targeted Bone Resorption
Plotkin, L. I. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0194-3 · Cited by 93
Weber, M. D., Frank, M. G., Sobesky, J. L., Watkins, L. R., & Maier, S. F. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.03.004 · Cited by 93
Xu, H., Su, Z., Wu, J., Yang, M., Penninger, J. M., Martin, C. M., Kvietys, P. R., & Rui, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902660 · Cited by 93
Xu, J., Guardado, J., Hoffman, R. A., Xu, H., Namas, R. A., Yoram Vodovotz, B., Xu, L., Ramadan, M., Brown, J. B., Turnquist, H. R., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002365 · Cited by 93
Self-citationSmoking and Endothelial Dysfunction
Golbidi, S., Edvinsson, L. I., & Laher, I. (2018) · Current Vascular Pharmacology · doi:10.2174/1573403x14666180913120015 · Cited by 97
Chelko, S. P., Keceli, G., Carpi, A., Doti, N., Agrimi, J., Asimaki, A., Beti, C. B., Miyamoto, M., Amat-Codina, N., Bedja, D., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf0891 · Cited by 92
The roles of odontoblasts in dental pulp innate immunity
Yumoto, H., Hirao, K., Hosokawa, Y., Kuramoto, H., Takegawa, D., Nakanishi, T., & Matsuo, T. (2018) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2018.03.001 · Cited by 99
Feng, T.-Y., Yang, Z.-K., Zheng, J.-W., Xie, Y., Li, D., Murugan, S. B., Yang, W., Liu, J., & Li, H. (2015) · Scientific Reports · doi:10.1038/srep10373 · Cited by 92
Nakamura, Y., Morioka, N., Abe, H., Zhang, F. F., Hisaoka‐Nakashima, K., Liu, K., Nishibori, M., & Nakata, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073640 · Cited by 89
Halayko, A. J., & Ghavami, S. (2009) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y09-054 · Cited by 90
The Functional Analysis of Histone Acetyltransferase MOF in Tumorigenesis
Su, J., Wang, F., Cai, Y., & Jin, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010099 · Cited by 88
Polymeric PD-L1 blockade nanoparticles for cancer photothermal-immunotherapy
Yu, Y., Li, J., Song, B., Ma, Z., Zhang, Y., Sun, H., Wei, X., Bai, Y., Lu, X., Zhang, P., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121312 · Cited by 89
Zhang, Y., Fang, C., Zhang, W., & Zhang, K. (2022) · Matter · doi:10.1016/j.matt.2022.08.026 · Cited by 88
Stanzione, R., Forte, M., Cotugno, M., Bianchi, F., Marchitti, S., & Rubattu, S. D. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00966-4 · Cited by 88
Asbestos induces mesothelial cell transformation via HMGB1-driven autophagy
Xue, J., Patergnani, S., Giorgi, C., Suarez, J. S., Goto, K., Bononi, A., Tanji, M., Novelli, F., Pastorino, S., Xu, R., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007622117 · Cited by 83
Toll-like receptors: sensing and reacting to diabetic injury in the kidney
Lin, M., & Tang, S. C. W. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft446 · Cited by 86
Adenovirus Core Proteins: Structure and Function
Kulanayake, S., & Tikoo, S. K. (2021) · Viruses · doi:10.3390/v13030388 · Cited by 85
Xu, D., Young, J. H.-W., Song, D., & Esko, J. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.299685 · Cited by 88
Rohde, D., Schön, C., Boerries, M., Didrihsone, I., Ritterhoff, J., Kubatzky, K. F., Völkers, M., Herzog, N., Mähler, M., Tsoporis, J. N., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201303498 · Cited by 86
Nativel, B., Marimoutou, M., Thon-Hon, V. G., Gunasekaran, M., Andries, J., Stanislas, G., Planesse, C., Silva, C. R. D., Césari, M., Iwema, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076039 · Cited by 81
HMGB1 blockade attenuates experimental autoimmune myocarditis and suppresses Th17‐cell expansion
Su, Z., Sun, C., Zhou, C., Liu, Y., Zhu, H., Sandoghchian, S., Zheng, D., Peng, T., Zhang, Y., Jiao, Z., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141879 · Cited by 81
HMGB1 and its physiological and pathological roles
Naglova, H., & Bucová, M. (2012) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2012_039 · Cited by 82
IL-33–mediated IL-13 secretion by ST2+ Tregs controls inflammation after lung injury
Liu, Q., Dwyer, G. K., Zhao, Y., Li, H., Mathews, L. R., Chakka, A. B., Chandran, U. R., Demetris, J. A., Alcorn, J. F., Robinson, K. M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.123919 · Cited by 80
Self-citationYang, Y., Li, X.-J., Chen, Z., Zhu, X.-X., Wang, J., Zhang, L., Qiang, L., Ma, Y., Li, Z., Guo, Q., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050811 · Cited by 80
Trauma in silico: Individual-specific mathematical models and virtual clinical populations
Brown, D., Namas, R. A., Almahmoud, K., Zaaqoq, A. M., Sarkar, J., Barclay, D. A., Yin, J., Ghuma, A., Abboud, A., Constantine, G. M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3636 · Cited by 80
Self-citationMcDonald, K.-A., Huang, H., Tohme, S. T., Loughran, P., Ferrero, K. M., Billiar, T. R., & Tsung, A. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00076 · Cited by 80
Self-citationTranslational Systems Approaches to the Biology of Inflammation and Healing
Yoram Vodovotz, B., Constantine, G. M., Faeder, J. R., Mi, Q., Rubin, J. E., Bartels, J. D., Sarkar, J., Squires, R. H., Okonkwo, D. O., Gerlach, J. C., et al. (2010) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970903369867 · Cited by 78
Wang, J., Li, R., Peng, Z., Hu, B., Rao, X., & Li, J. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4402 · Cited by 78
The Role of Glycyrrhizin, an Inhibitor of HMGB1 Protein, in Anticancer Therapy
Smolarczyk, R., Cichoń, T., Matuszczak, S., Mitrus, I., Lesiak, M., Kobusińska, M., Kamysz, W., Jarosz–Biej, M., Sieroń, A. L., & Szala, S. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0183-0 · Cited by 80
Fan, H., Li, L., Zhang, X., Liu, Y., Yang, C., Yang, Y., & Yin, J. (2009) · Mediators of Inflammation · doi:10.1155/2009/704706 · Cited by 78
Farhood, B., Goradel, N. H., Mortezaee, K., Khanlarkhani, N., Salehi, E., Nashtaei, M. S., Shabeeb, D., Musa, A. E., Fallah, H., & Najafi, M. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-0473-3 · Cited by 78
Zhang, J.-J., Peng, K., Zhang, J., Meng, X., & Ji, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172006 · Cited by 77
Sharma, A. K., LaPar, D. J., Stone, M. L., Zhao, Y., Kron, I. L., & Laubach, V. E. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12368 · Cited by 79
Immunogenic cell death in cancer immunotherapy
Choi, M., Shin, J., Lee, C.-E., Chung, J.-Y., Kim, M., Yan, X., Yang, W., & Cha, J. (2023) · BMB Reports · doi:10.5483/bmbrep.2023-0024 · Cited by 79
Loukili, N., Rosenblatt‐Velin, N., Ju, L., Rignault-Clerc, S., Pacher, P., Feihl, F., Waeber, B., & Liaudet, L. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq373 · Cited by 76
Zhu, L., Li, X., Chen, Y., Fang, J., & Ge, Z. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.012 · Cited by 76
Saha, B., Tornai, D., Kodys, K., Adejumo, A., Lowe, P., McClain, C. J., Mitchell, M. C., McCullough, A. J., Dasarathy, S., Kroll‐Desrosiers, A., et al. (2019) · Hepatology · doi:10.1002/hep.30617 · Cited by 75
HMGB 1 mediates hyperglycaemia‐induced cardiomyocyte apoptosis via ERK /Ets‐1 signalling pathway
Wang, W., Lu, Q., Zhang, J., Wang, B., Liu, X., An, F., Qin, W., Chen, X., Dong, W., Zhang, C., et al. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12399 · Cited by 75
The Role of HMGB1 in Cardiovascular Biology: Danger Signals
Cai, J., Wen, J., Bauer, E. M., Zhong, H., Yuan, H., & Chen, A. F. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6408 · Cited by 72
Killeen, A., Morris, D., Kenny, D., Mullen, M., Diskin, M., & Waters, S. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-234 · Cited by 70
Zhang, J., Xu, X., Rao, N. V., Argyle, B., McCoard, L., Rusho, W. J., Kennedy, T. P., Prestwich, G. D., & Krueger, G. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016658 · Cited by 73
The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction
Weber, D. J., Allette, Y. M., Wilkes, D. S., & White, F. A. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6299 · Cited by 77
Karlstetter, M., Walczak, Y., Weigelt, K., Ebert, S., den Brulle, J. V., Schwer, H., Fuchshofer, R., & Langmann, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903300 · Cited by 70
A tale of two proteins: PACT and PKR and their roles in inflammation
Chukwurah, E., Farabaugh, K. T., Guan, B., Ramakrishnan, P., & Hatzoglou, M. (2021) · FEBS Journal · doi:10.1111/febs.15691 · Cited by 73
Bouchet, A., Sakakini, N., Atifi, M. E., Clec’h, C. L., Bräuer‐Krisch, E., Moisan, A., Deman, P., Rihet, P., Duc, G. L., & Pelletier, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081874 · Cited by 76
High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons
Al-Kuraishy, H. M., Al-Gareeb, A. I., Alkazmi, L. M., Habotta, O. A., & Batiha, G. E. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-00988-y · Cited by 73
Sundberg, E., Fasth, A. E. R., Palmblad, K., Harris, H. E., & Andersson, U. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.09.006 · Cited by 71
Immune-Modulating Perspectives for Low Frequency Electromagnetic Fields in Innate Immunity
Rosado, M. M., Simkó, M., Mattsson, M., & Pioli, C. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00085 · Cited by 71
Immunoinflammatory Response in Critically Ill Patients: Severe Sepsis and/or Trauma
Šurbatović, M., Veljović, M., Jevdjic, J., Popović, N., Djordjevic, D., & Radakovic, S. (2013) · Mediators of Inflammation · doi:10.1155/2013/362793 · Cited by 69
Role of Apoptosis in Amplifying Inflammatory Responses in Lung Diseases
Schmidt, E. P., & Tuder, R. M. (2010) · Journal of Cell Death · doi:10.4137/jcd.s5375 · Cited by 70
The Prion Hypothesis of Parkinson’s Disease
Chu, Y., & Kordower, J. H. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0549-x · Cited by 74
Evolving role of biomarkers in acute cerebrovascular disease
Kernagis, D., & Laskowitz, D. T. (2011) · Annals of Neurology · doi:10.1002/ana.22553 · Cited by 71
Mamilos, A., Winter, L., Schmitt, V. H., Barsch, F., Grevenstein, D., Wagner, W. L., Babel, M., Keller, K., Schmitt, C., Gürtler, F., et al. (2023) · Cells · doi:10.3390/cells12020276 · Cited by 75
Tadié, J., Bae, H., Deshane, J. S., Bell, C. P., Lazarowski, E. R., Chaplin, D., Thannickal, V. J., Abraham, E. H., & Zmijewski, J. W. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00401 · Cited by 70
Astrocytes as a target for therapeutic strategies in epilepsy: current insights
Çarçak, N., Onat, F., & Sitnikova, E. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1183775 · Cited by 70
Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury
Zampell, J. C., Elhadad, S., Avraham, T., Weitman, E. S., Aschen, S. Z., Yan, A., & Mehrara, B. J. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00284.2011 · Cited by 68
Emerging role of innate immunity in organ transplantation
Land, W. G. (2011) · Transplantation Reviews · doi:10.1016/j.trre.2011.05.001 · Cited by 68
Li, M., Song, L., Gao, X., Chang, W., & Qin, X. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.4.021 · Cited by 69
Danger in the Intensive Care Unit
Timmermans, K., Kox, M., Scheffer, G. J., & Pickkers, P. (2015) · Shock · doi:10.1097/shk.0000000000000506 · Cited by 70
Dong, L., Chen, F., Xu, M., Yao, L., Zhang, Y., & Zhuang, Y. (2018) · Europe PMC (PubMed Central) · Cited by 67
Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation
Anfinogenova, Y., Quinn, M. T., Schepetkin, I. A., & Atochin, D. N. (2020) · Cells · doi:10.3390/cells9112350 · Cited by 68
High-mobility group box-1 was released actively and involved in LPS induced depressive-like behavior
Wu, T., Liu, L., Zhang, W., Zhang, Y., Liu, Y., Shen, X.-L., Gong, H., Yang, Y., Bi, X., Jiang, C., et al. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.02.016 · Cited by 70
Zhou, Z., Hou, J., Mo, Y., Ren, M., Yang, G., Qu, Z., & Hu, Y. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172857 · Cited by 69
Soluble receptor for advanced glycation end-products and progression of airway disease
Iwamoto, H., Gao, J., Pulkkinen, V., Toljamo, T., Nieminen, P. A., & Mazur, W. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-68 · Cited by 66
Maeda, A., Kawamura, T., Ueno, T., Usui, N., Eguchi, H., & Miyagawa, S. (2013) · Transplant Immunology · doi:10.1016/j.trim.2013.08.001 · Cited by 66
Targeting Toll‐like receptor‐4 to tackle preterm birth and fetal inflammatory injury
Robertson, S. A., Hutchinson, M. R., Rice, K. C., Chin, P. Y., Moldenhauer, L. M., Stark, M. J., Olson, D. M., & Keelan, J. A. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1121 · Cited by 68
Ziegler, K., Kunert, A. T., Reinmuth-Selzle, K., Leifke, A. L., Widera, D., Weller, M. G., Schuppan, D., Fröhlich‐Nowoisky, J., Lucas, K., & Pöschl, U. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101581 · Cited by 66
The p38MAPK-MK2 Signaling Axis as a Critical Link Between Inflammation and Synaptic Transmission
Beamer, E. H., & Corrêa, S. A. L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.635636 · Cited by 64
Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies
Muccioli, M., & Benencia, F. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00341 · Cited by 65
Ackermann, M. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35775-3.00003-5 · Cited by 69
High Mobility Group Box 1 in Human Cancer
Rapoport, B. L., Steel, H. C., Theron, A. J., Heyman, L., Smit, T., Ramdas, Y., & Anderson, R. (2020) · Cells · doi:10.3390/cells9071664 · Cited by 68
Lin, F., Shan, W., Zheng, Y., Pan, L., & Zuo, Z. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15368 · Cited by 64
Extracellular Heat Shock Proteins: Alarmins for the Host Immune System
Wheeler, D. S. (2011) · The Open Inflammation Journal · doi:10.2174/1875041901104010049 · Cited by 65
Lau, A. N., Wang, S., Liu, W., Haig, A. R., Zhang, Z., & Jevnikar, A. M. (2014) · American Journal of Nephrology · doi:10.1159/000364908 · Cited by 64
Huang, J., Liu, B., Yang, C., Chen, H., Eunice, D., & Yuan, Z. (2013) · Brain Research · doi:10.1016/j.brainres.2013.08.057 · Cited by 66
Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy
Dong, H., Zhang, L., & Liu, S. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.73504 · Cited by 64
Yaser, A.-M., Huang, Y., Zhou, R.-R., Hu, G.-S., Xiao, M.-F., Huang, Z.-B., Duan, C.-J., Tian, W., Tang, D., & Fan, X. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13055982 · Cited by 63
Johnson, L., Atanasova, K. R., Bui, P. Q., Lee, J., Hung, S.-C., Yilmaz, Ö., & Ojcius, D. M. (2015) · Microbes and Infection · doi:10.1016/j.micinf.2015.03.010 · Cited by 63
Albayrak, A., Uyanik, M. H., Cerrah, S., Altaş, S., Dursun, H., Demir, M. T., & Uslu, H. (2010) · Viral Immunology · doi:10.1089/vim.2010.0080 · Cited by 63
High-mobility group box 1 protein and its role in severe acute pancreatitis
Shen, X. L. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i5.1424 · Cited by 61
An, G. C., Bartels, J. D., & Yoram Vodovotz, B. (2010) · Drug Development Research · doi:10.1002/ddr.20415 · Cited by 60
Metadata
- Authors
- Klune, J. R., Dhupar, R., Cardinal, J., Billiar, T. R., & Tsung, A.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Tsung, Allan
- Venue
- Molecular Medicine
- Published
- 2008-04-11
- Volume
- 14
- Issue
- 7-8
- Pages
- 476-484
- ISSN
- 1076-1551 (ISSN-L)
- 1528-3658
- PMC
- PMC2323334
- OpenAlex
- W168035116
- Cited by
- 762
- References
- 129
- Citations by year
- 2026: 14 · 2025: 15 · 2024: 29 · 2023: 32 · 2022: 35 · 2021: 47 · 2020: 53 · 2019: 53 · 2018: 48 · 2017: 44 · 2016: 45 · 2015: 55 · 2014: 54 · 2013: 48 · 2012: 45
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Molecular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- HMGB1, alarmins, danger signaling, innate immunity, inflammation, sepsis, autoimmunity, cancer, trauma (physical injury), ischemia-reperfusion injury, tissue repair, regeneration
- MeSH terms
- Receptor for Advanced Glycation End Products, Animals, Cell Nucleus, Disease, Humans, Immunity, Innate, Models, Biological, Receptors, Immunologic, Regeneration, Signal Transduction, Inflammation Mediators, HMGB1 Protein, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review